DANA BAGEON: Open Payments
NPI 1417205949 · WAYZATA, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 6 payments from 6 companies in 2025. Trend: 2023 $2,095 · 2024 $1,223 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 1 | $143 |
| Tris Pharma Inc | 1 | $120 |
| Novo Nordisk Inc | 1 | $103 |
| Axsome Therapeutics, Inc. | 1 | $37 |
| Alkermes, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: Dyanavel XR, Auvelity, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across MN — which companies pay providers there.
